English
简体中文
Total: £ 56.28
Published Date: 2025-10-17 | Pages: 139 | Tables: 133 | Medical Devices & Consumables
The global Cardiopulmonary Assisted Membrane Oxygenator market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Extracorporeal Membrane Oxygenation (ECMO) is an extracorporeal life support device used to support and replace patients with severe heart or lung failure. ECMO helps maintain normal oxygen levels and carbon dioxide removal in the body by draining the patient's blood from the body to a device outside the body where gas exchange (oxygenation and carbon dioxide removal) occurs and then returning the blood to the body.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Cardiopulmonary Assisted Membrane Oxygenator leading manufacturers including GETINGE, PROCIRCA, Perfusion Solution, Vivacity Perfusion, SpecialtyCare, Keystone Perfusion Services, Comprehensive Care Services, Memorial, etc., dominate supply; the top five capture approximately % of global revenue, with GETINGE leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Cardiopulmonary Assisted Membrane Oxygenator market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
GETINGE
PROCIRCA
Perfusion Solution
Vivacity Perfusion
SpecialtyCare
Keystone Perfusion Services
Comprehensive Care Services
Memorial
Segment by Type
VA (veno-arterial) ECMO
VV (veno-venous) ECMO
Segment by Application
Hospital
Clinic
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Cardiopulmonary Assisted Membrane Oxygenator study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Cardiopulmonary Assisted Membrane Oxygenator: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Cardiopulmonary Assisted Membrane Oxygenator Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 VA (veno-arterial) ECMO
1.2.3 VV (veno-venous) ECMO
1.3 Market Segmentation by Application
1.3.1 Global Cardiopulmonary Assisted Membrane Oxygenator Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Estimates and Forecasts 2020-2031
2.2 Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Cardiopulmonary Assisted Membrane Oxygenator Sales Estimates and Forecasts 2020-2031
2.4 Global Cardiopulmonary Assisted Membrane Oxygenator Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Cardiopulmonary Assisted Membrane Oxygenator Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Cardiopulmonary Assisted Membrane Oxygenator Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 VA (veno-arterial) ECMO Market Size by Manufacturers
3.5.2 VV (veno-venous) ECMO Market Size by Manufacturers
3.6 Global Cardiopulmonary Assisted Membrane Oxygenator Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Cardiopulmonary Assisted Membrane Oxygenator Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Cardiopulmonary Assisted Membrane Oxygenator Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Cardiopulmonary Assisted Membrane Oxygenator Sales and Revenue by Type (2020-2031)
6.4 North America Cardiopulmonary Assisted Membrane Oxygenator Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Cardiopulmonary Assisted Membrane Oxygenator Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Cardiopulmonary Assisted Membrane Oxygenator Sales and Revenue by Type (2020-2031)
7.4 Europe Cardiopulmonary Assisted Membrane Oxygenator Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Cardiopulmonary Assisted Membrane Oxygenator Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Cardiopulmonary Assisted Membrane Oxygenator Sales and Revenue by Type (2020-2031)
9.4 Central and South America Cardiopulmonary Assisted Membrane Oxygenator Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Cardiopulmonary Assisted Membrane Oxygenator Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Cardiopulmonary Assisted Membrane Oxygenator Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Cardiopulmonary Assisted Membrane Oxygenator Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Cardiopulmonary Assisted Membrane Oxygenator Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 GETINGE
11.1.1 GETINGE Corporation Information
11.1.2 GETINGE Business Overview
11.1.3 GETINGE Cardiopulmonary Assisted Membrane Oxygenator Product Models, Descriptions and Specifications
11.1.4 GETINGE Cardiopulmonary Assisted Membrane Oxygenator Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 GETINGE Cardiopulmonary Assisted Membrane Oxygenator Sales by Product in 2024
11.1.6 GETINGE Cardiopulmonary Assisted Membrane Oxygenator Sales by Application in 2024
11.1.7 GETINGE Cardiopulmonary Assisted Membrane Oxygenator Sales by Geographic Area in 2024
11.1.8 GETINGE Cardiopulmonary Assisted Membrane Oxygenator SWOT Analysis
11.1.9 GETINGE Recent Developments
11.2 PROCIRCA
11.2.1 PROCIRCA Corporation Information
11.2.2 PROCIRCA Business Overview
11.2.3 PROCIRCA Cardiopulmonary Assisted Membrane Oxygenator Product Models, Descriptions and Specifications
11.2.4 PROCIRCA Cardiopulmonary Assisted Membrane Oxygenator Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 PROCIRCA Cardiopulmonary Assisted Membrane Oxygenator Sales by Product in 2024
11.2.6 PROCIRCA Cardiopulmonary Assisted Membrane Oxygenator Sales by Application in 2024
11.2.7 PROCIRCA Cardiopulmonary Assisted Membrane Oxygenator Sales by Geographic Area in 2024
11.2.8 PROCIRCA Cardiopulmonary Assisted Membrane Oxygenator SWOT Analysis
11.2.9 PROCIRCA Recent Developments
11.3 Perfusion Solution
11.3.1 Perfusion Solution Corporation Information
11.3.2 Perfusion Solution Business Overview
11.3.3 Perfusion Solution Cardiopulmonary Assisted Membrane Oxygenator Product Models, Descriptions and Specifications
11.3.4 Perfusion Solution Cardiopulmonary Assisted Membrane Oxygenator Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Perfusion Solution Cardiopulmonary Assisted Membrane Oxygenator Sales by Product in 2024
11.3.6 Perfusion Solution Cardiopulmonary Assisted Membrane Oxygenator Sales by Application in 2024
11.3.7 Perfusion Solution Cardiopulmonary Assisted Membrane Oxygenator Sales by Geographic Area in 2024
11.3.8 Perfusion Solution Cardiopulmonary Assisted Membrane Oxygenator SWOT Analysis
11.3.9 Perfusion Solution Recent Developments
11.4 Vivacity Perfusion
11.4.1 Vivacity Perfusion Corporation Information
11.4.2 Vivacity Perfusion Business Overview
11.4.3 Vivacity Perfusion Cardiopulmonary Assisted Membrane Oxygenator Product Models, Descriptions and Specifications
11.4.4 Vivacity Perfusion Cardiopulmonary Assisted Membrane Oxygenator Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Vivacity Perfusion Cardiopulmonary Assisted Membrane Oxygenator Sales by Product in 2024
11.4.6 Vivacity Perfusion Cardiopulmonary Assisted Membrane Oxygenator Sales by Application in 2024
11.4.7 Vivacity Perfusion Cardiopulmonary Assisted Membrane Oxygenator Sales by Geographic Area in 2024
11.4.8 Vivacity Perfusion Cardiopulmonary Assisted Membrane Oxygenator SWOT Analysis
11.4.9 Vivacity Perfusion Recent Developments
11.5 SpecialtyCare
11.5.1 SpecialtyCare Corporation Information
11.5.2 SpecialtyCare Business Overview
11.5.3 SpecialtyCare Cardiopulmonary Assisted Membrane Oxygenator Product Models, Descriptions and Specifications
11.5.4 SpecialtyCare Cardiopulmonary Assisted Membrane Oxygenator Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 SpecialtyCare Cardiopulmonary Assisted Membrane Oxygenator Sales by Product in 2024
11.5.6 SpecialtyCare Cardiopulmonary Assisted Membrane Oxygenator Sales by Application in 2024
11.5.7 SpecialtyCare Cardiopulmonary Assisted Membrane Oxygenator Sales by Geographic Area in 2024
11.5.8 SpecialtyCare Cardiopulmonary Assisted Membrane Oxygenator SWOT Analysis
11.5.9 SpecialtyCare Recent Developments
11.6 Keystone Perfusion Services
11.6.1 Keystone Perfusion Services Corporation Information
11.6.2 Keystone Perfusion Services Business Overview
11.6.3 Keystone Perfusion Services Cardiopulmonary Assisted Membrane Oxygenator Product Models, Descriptions and Specifications
11.6.4 Keystone Perfusion Services Cardiopulmonary Assisted Membrane Oxygenator Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Keystone Perfusion Services Recent Developments
11.7 Comprehensive Care Services
11.7.1 Comprehensive Care Services Corporation Information
11.7.2 Comprehensive Care Services Business Overview
11.7.3 Comprehensive Care Services Cardiopulmonary Assisted Membrane Oxygenator Product Models, Descriptions and Specifications
11.7.4 Comprehensive Care Services Cardiopulmonary Assisted Membrane Oxygenator Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Comprehensive Care Services Recent Developments
11.8 Memorial
11.8.1 Memorial Corporation Information
11.8.2 Memorial Business Overview
11.8.3 Memorial Cardiopulmonary Assisted Membrane Oxygenator Product Models, Descriptions and Specifications
11.8.4 Memorial Cardiopulmonary Assisted Membrane Oxygenator Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Memorial Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Cardiopulmonary Assisted Membrane Oxygenator Industry Chain
12.2 Cardiopulmonary Assisted Membrane Oxygenator Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Cardiopulmonary Assisted Membrane Oxygenator Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Cardiopulmonary Assisted Membrane Oxygenator Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Cardiopulmonary Assisted Membrane Oxygenator Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Cardiopulmonary Assisted Membrane Oxygenator Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global Cardiopulmonary Assisted Membrane Oxygenator Sales by Region (2020-2025) & (Units)
Table 8. Global Cardiopulmonary Assisted Membrane Oxygenator Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Cardiopulmonary Assisted Membrane Oxygenator Sales by Manufacturers (2020-2025) & (Units)
Table 11. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Share by Manufacturers (2020-2025)
Table 12. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Cardiopulmonary Assisted Membrane Oxygenator by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiopulmonary Assisted Membrane Oxygenator as of 2024)
Table 16. Global Cardiopulmonary Assisted Membrane Oxygenator Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Cardiopulmonary Assisted Membrane Oxygenator Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Cardiopulmonary Assisted Membrane Oxygenator Manufacturing Base and Headquarters
Table 19. Global Cardiopulmonary Assisted Membrane Oxygenator Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2020-2025) & (Units)
Table 23. Global Cardiopulmonary Assisted Membrane Oxygenator Sales by Type (2026-2031) & (Units)
Table 24. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Cardiopulmonary Assisted Membrane Oxygenator ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Cardiopulmonary Assisted Membrane Oxygenator Sales by Application (2020-2025) & (Units)
Table 29. Global Cardiopulmonary Assisted Membrane Oxygenator Sales by Application (2026-2031) & (Units)
Table 30. Cardiopulmonary Assisted Membrane Oxygenator High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Cardiopulmonary Assisted Membrane Oxygenator ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Cardiopulmonary Assisted Membrane Oxygenator Growth Accelerators and Market Barriers
Table 37. North America Cardiopulmonary Assisted Membrane Oxygenator Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Cardiopulmonary Assisted Membrane Oxygenator Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Cardiopulmonary Assisted Membrane Oxygenator Growth Accelerators and Market Barriers
Table 40. Europe Cardiopulmonary Assisted Membrane Oxygenator Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Growth Accelerators and Market Barriers
Table 45. Southeast Asia Cardiopulmonary Assisted Membrane Oxygenator Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Cardiopulmonary Assisted Membrane Oxygenator Investment Opportunities and Key Challenges
Table 47. Central and South America Cardiopulmonary Assisted Membrane Oxygenator Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Cardiopulmonary Assisted Membrane Oxygenator Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Cardiopulmonary Assisted Membrane Oxygenator Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. GETINGE Corporation Information
Table 51. GETINGE Description and Major Businesses
Table 52. GETINGE Product Models, Descriptions and Specifications
Table 53. GETINGE Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. GETINGE Sales Value Proportion by Product in 2024
Table 55. GETINGE Sales Value Proportion by Application in 2024
Table 56. GETINGE Sales Value Proportion by Geographic Area in 2024
Table 57. GETINGE Cardiopulmonary Assisted Membrane Oxygenator SWOT Analysis
Table 58. GETINGE Recent Developments
Table 59. PROCIRCA Corporation Information
Table 60. PROCIRCA Description and Major Businesses
Table 61. PROCIRCA Product Models, Descriptions and Specifications
Table 62. PROCIRCA Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. PROCIRCA Sales Value Proportion by Product in 2024
Table 64. PROCIRCA Sales Value Proportion by Application in 2024
Table 65. PROCIRCA Sales Value Proportion by Geographic Area in 2024
Table 66. PROCIRCA Cardiopulmonary Assisted Membrane Oxygenator SWOT Analysis
Table 67. PROCIRCA Recent Developments
Table 68. Perfusion Solution Corporation Information
Table 69. Perfusion Solution Description and Major Businesses
Table 70. Perfusion Solution Product Models, Descriptions and Specifications
Table 71. Perfusion Solution Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Perfusion Solution Sales Value Proportion by Product in 2024
Table 73. Perfusion Solution Sales Value Proportion by Application in 2024
Table 74. Perfusion Solution Sales Value Proportion by Geographic Area in 2024
Table 75. Perfusion Solution Cardiopulmonary Assisted Membrane Oxygenator SWOT Analysis
Table 76. Perfusion Solution Recent Developments
Table 77. Vivacity Perfusion Corporation Information
Table 78. Vivacity Perfusion Description and Major Businesses
Table 79. Vivacity Perfusion Product Models, Descriptions and Specifications
Table 80. Vivacity Perfusion Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Vivacity Perfusion Sales Value Proportion by Product in 2024
Table 82. Vivacity Perfusion Sales Value Proportion by Application in 2024
Table 83. Vivacity Perfusion Sales Value Proportion by Geographic Area in 2024
Table 84. Vivacity Perfusion Cardiopulmonary Assisted Membrane Oxygenator SWOT Analysis
Table 85. Vivacity Perfusion Recent Developments
Table 86. SpecialtyCare Corporation Information
Table 87. SpecialtyCare Description and Major Businesses
Table 88. SpecialtyCare Product Models, Descriptions and Specifications
Table 89. SpecialtyCare Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. SpecialtyCare Sales Value Proportion by Product in 2024
Table 91. SpecialtyCare Sales Value Proportion by Application in 2024
Table 92. SpecialtyCare Sales Value Proportion by Geographic Area in 2024
Table 93. SpecialtyCare Cardiopulmonary Assisted Membrane Oxygenator SWOT Analysis
Table 94. SpecialtyCare Recent Developments
Table 95. Keystone Perfusion Services Corporation Information
Table 96. Keystone Perfusion Services Description and Major Businesses
Table 97. Keystone Perfusion Services Product Models, Descriptions and Specifications
Table 98. Keystone Perfusion Services Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Keystone Perfusion Services Recent Developments
Table 100. Comprehensive Care Services Corporation Information
Table 101. Comprehensive Care Services Description and Major Businesses
Table 102. Comprehensive Care Services Product Models, Descriptions and Specifications
Table 103. Comprehensive Care Services Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Comprehensive Care Services Recent Developments
Table 105. Memorial Corporation Information
Table 106. Memorial Description and Major Businesses
Table 107. Memorial Product Models, Descriptions and Specifications
Table 108. Memorial Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Memorial Recent Developments
Table 110. Key Raw Materials Distribution
Table 111. Raw Materials Key Suppliers
Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 113. Milestones in Production Technology Evolution
Table 114. Distributors List
Table 115. Market Trends and Market Evolution
Table 116. Market Drivers and Opportunities
Table 117. Market Challenges, Risks, and Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Cardiopulmonary Assisted Membrane Oxygenator Product Picture
Figure 2. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. VA (veno-arterial) ECMO Product Picture
Figure 4. VV (veno-venous) ECMO Product Picture
Figure 5. Global Cardiopulmonary Assisted Membrane Oxygenator Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Cardiopulmonary Assisted Membrane Oxygenator Report Years Considered
Figure 10. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2031) & (US$ Million)
Figure 12. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Region (2020-2031)
Figure 14. Global Cardiopulmonary Assisted Membrane Oxygenator Sales (2020-2031) & (Units)
Figure 15. Global Cardiopulmonary Assisted Membrane Oxygenator Sales (CAGR) by Region (2020-2031) (Units)
Figure 16. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Cardiopulmonary Assisted Membrane Oxygenator Sales Volume Market Share in 2024
Figure 18. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. VA (veno-arterial) ECMO Revenue Market Share by Manufacturer in 2024
Figure 21. VV (veno-venous) ECMO Revenue Market Share by Manufacturer in 2024
Figure 22. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Type (2020-2031)
Figure 23. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Type (2020-2031)
Figure 24. Global Cardiopulmonary Assisted Membrane Oxygenator Sales Market Share by Application (2020-2031)
Figure 25. Global Cardiopulmonary Assisted Membrane Oxygenator Revenue Market Share by Application (2020-2031)
Figure 26. North America Cardiopulmonary Assisted Membrane Oxygenator Sales YoY (2020-2031) & (Units)
Figure 27. North America Cardiopulmonary Assisted Membrane Oxygenator Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Cardiopulmonary Assisted Membrane Oxygenator Sales Revenue (US$ Million) in 2024
Figure 29. North America Cardiopulmonary Assisted Membrane Oxygenator Sales Volume (Units) by Type (2020- 2031)
Figure 30. North America Cardiopulmonary Assisted Membrane Oxygenator Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Cardiopulmonary Assisted Membrane Oxygenator Sales Volume (Units) by Application (2020-2031)
Figure 32. North America Cardiopulmonary Assisted Membrane Oxygenator Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales YoY (2020-2031) & (Units)
Figure 37. Europe Cardiopulmonary Assisted Membrane Oxygenator Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Cardiopulmonary Assisted Membrane Oxygenator Sales Revenue (US$ Million) in 2024
Figure 39. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales Volume (Units) by Type (2020-2031)
Figure 40. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales Volume (Units) by Application (2020-2031)
Figure 42. Europe Cardiopulmonary Assisted Membrane Oxygenator Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2031) & (US$ Million)
Figure 44. France Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Sales YoY (2020-2031) & (Units)
Figure 49. Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Cardiopulmonary Assisted Membrane Oxygenator Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Sales Volume (Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Sales Volume (Units) by Application (2020-2031)
Figure 54. Asia-Pacific Cardiopulmonary Assisted Membrane Oxygenator Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2031) & (US$ Million)
Figure 59. India Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Cardiopulmonary Assisted Membrane Oxygenator Sales YoY (2020-2031) & (Units)
Figure 61. Central and South America Cardiopulmonary Assisted Membrane Oxygenator Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Cardiopulmonary Assisted Membrane Oxygenator Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Cardiopulmonary Assisted Membrane Oxygenator Sales Volume (Units) by Type (2021-2031)
Figure 64. Central and South America Cardiopulmonary Assisted Membrane Oxygenator Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Cardiopulmonary Assisted Membrane Oxygenator Sales Volume (Units) by Application (2020-2031)
Figure 66. Central and South America Cardiopulmonary Assisted Membrane Oxygenator Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Cardiopulmonary Assisted Membrane Oxygenator Sales YoY (2020-2031) & (Units)
Figure 70. Middle East and Africa Cardiopulmonary Assisted Membrane Oxygenator Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Cardiopulmonary Assisted Membrane Oxygenator Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Cardiopulmonary Assisted Membrane Oxygenator Sales Volume (Units) by Type (2021-2031)
Figure 73. South America Cardiopulmonary Assisted Membrane Oxygenator Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Cardiopulmonary Assisted Membrane Oxygenator Sales Volume (Units) by Application (2020-2031)
Figure 75. Middle East and Africa Cardiopulmonary Assisted Membrane Oxygenator Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Cardiopulmonary Assisted Membrane Oxygenator Revenue (2020-2025) & (US$ Million)
Figure 80. Cardiopulmonary Assisted Membrane Oxygenator Industry Chain Mapping
Figure 81. Regional Cardiopulmonary Assisted Membrane Oxygenator Manufacturing Base Distribution (%)
Figure 82. Global Cardiopulmonary Assisted Membrane Oxygenator Production Market Share by Region (2020-2031)
Figure 83. Cardiopulmonary Assisted Membrane Oxygenator Production Process
Figure 84. Regional Cardiopulmonary Assisted Membrane Oxygenator Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
